Skip to main content

Advertisement

SpringerLink
Log in

Two-Staged Surgery for Metastatic Liver Tumor in Morbidly Obese Individual-Left Hemihepatectomy Following Placement of Laparoscopic Adjustable Gastric Band

  • Case Report
  • Published:
Obesity Surgery Aims and scope Submit manuscript

Abstract

A 47-year-oldmale with a body mass index (BMI) 37.12 kg/m2 was diagnosed with an ill-demarcated tumor within IVB segment of left lobe of the liver. Sixteen months earlier, he underwent laparoscopic gastric banding for morbid obesity (BMI 51 kg/m2). One year after bariatric procedure, he was diagnosed with rectal adenocarcinoma. Following abdominoperineal resection of rectum with total mesorectal excision and 2 months course of adjuvant FOLFOX chemotherapy, he was scheduled for liver resection. Left hemihepatectomy was performed with no major complications; wound discharge was successfully treated in outpatient clinic. Twelve months following surgery, he remains disease free with no evidence of local recurrence, metachronic primary tumor, or distant metastases. This is first to our knowledge report providing data on the outcome of left hemihepatectomy performed in postbariatric patient. The role of bariatric surgery and utilization of the time necessary for neoadjuvant chemotherapy to reduce the excessive body mass and the degree of liver steatosis is discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

References

  1. Barrett AM, Boye KS, Oyelowo O. Burden of obesity: 10-year review of the literature on obesity prevalence in nine countries. ISPOR 13th annual international meeting.

  2. American Society for Bariatric Surgery and Society of American Gastrointestinal Endoscopic Surgeons. Guidelines for laparoscopic and open surgical treatment of morbid obesity. Obes Surg 2000;10:378–9.

    Google Scholar 

  3. O’Brien P, Brown W, Smith A, et al. Prospective study of a laparoscopically placed, adjustable gastric band in the treatment of morbid obesity. Br J Surg. 1999;86:113–8.

    Article  PubMed  Google Scholar 

  4. Chapman AE, Kiroff G, Game P, et al. Laparoscopic adjustable gastric banding in the treatment of obesity; a systematic literature review. Surgery. 2004;135:326–51.

    Article  PubMed  Google Scholar 

  5. Zinzindohoue F, Chevalier J, Douard R, et al. Laparoscopic gastric banding: a minimally invasive surgical treatment for morbid obesity: prospective study of 500 consecutive patients. Ann Surg. 2003;237:1–9.

    Article  PubMed  Google Scholar 

  6. Ponce J, Paynter S, Fromm R. Laparoscopic adjustable gastric banding: 1014 consecutive cases. J Am Coll Surg. 2005;201:529–35.

    Article  PubMed  Google Scholar 

  7. O’Brien PE, Dixon JB. Pars flaccida versus perigastric pathways for the placement of the Lap Band system. Obes Surg. 2003;13:211.

    Google Scholar 

  8. Choti MA, Sitzmann JV, Tiburi MF, et al. Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg. 2002;235(6):759–66.

    Article  PubMed  Google Scholar 

  9. Abdalla EK, Vauthey JN, Ellis LM, et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg. 2004;239(6):818–25.

    Article  PubMed  Google Scholar 

  10. Fernandez FG, Drebin JA, Linehan DC, et al. Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET). Ann Surg. 2004;240(3):438–47.

    Article  PubMed  Google Scholar 

  11. Pawlik TM, Scoggins CR, Zorzi D, et al. Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg. 2005;241:715–24.

    Article  PubMed  Google Scholar 

  12. Klasen J, Junger A, Hartmann B, et al. Increased body mass index and peri-operative risk in patients undergoing non-cardiac surgery. Obes Surg. 2004;14:275–81.

    Article  PubMed  Google Scholar 

  13. Gedaly R, McHugh PP, Johnston TD, et al. Obesity, diabetes, and smoking are important determinants of resource utilization in liver resection: a multicenter analysis of 1029 patients. Ann Surg. 2009;249(3):414–9.

    Article  PubMed  Google Scholar 

  14. Browning JD, Szczepaniak LS, Dobbins R, et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology. 2004;40(6):1387–95.

    Article  PubMed  Google Scholar 

  15. Bedogni G, Bellentani S. Fatty liver: how frequent is it and why? Ann Hepatol. 2004;3(2):63–5.

    PubMed  Google Scholar 

  16. Veteläinen R, van Vliet A, Gouma DJ, et al. Steatosis as a risk factor in liver surgery. Ann Surg. 2007;245(1):20–30.

    Article  PubMed  Google Scholar 

  17. Rinella ME, Alonso E, Rao S, et al. Body mass index as a predictor of hepatic steatosis in living liver donors. Liver Transpl. 2001;7(5):409–14.

    Article  CAS  PubMed  Google Scholar 

  18. Nair S, Verma S, Thuluvath PJ. Obesity and its effect on survival in patients undergoing orthotopic liver transplantation in the United States. Hepatology. 2002;35(1):105–9.

    Article  PubMed  Google Scholar 

  19. Bonanomi G, Mandalà L, Maruzzelli L. Laparoscopic staged adjustable gastric banding and liver resection in morbidly obese patient. Obes Surg 2008; in press.

  20. Chua TC, Saxena A, Liauw W, et al. Systematic review of randomized and nonrandomized trials of the clinical response and outcomes of neoadjuvant systemic chemotherapy for resectable colorectal liver metastases. Ann Surg Oncol. 2009;17:492–501.

    Article  PubMed  Google Scholar 

  21. Benoist S, Nordlinger B. The role of preoperative chemotherapy in patients with resectable colorectal liver metastases. Ann Surg Oncol. 2009;16(9):2385–90.

    Article  PubMed  Google Scholar 

  22. Barakat O, Skolkin MD, Toombs BD, et al. Major liver resection for hepatocellular carcinoma in the morbidly obese: a proposed strategy to improve outcome. World J Surg Oncol. 2008;6:100.

    Article  PubMed  Google Scholar 

  23. Modanlou KA, Muthyala U, Xiao H, et al. Bariatric surgery among kidney transplant candidates and recipients: analysis of the United States renal data system and literature review. Transplantation. 2009;87(8):1167–73.

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

The authors declare that they have no conflict of interest

Author information

Authors and Affiliations

  1. Department of General and Transplant Surgery, Norbert Barlicki Memorial Teaching Hospital, Medical University of Lodz, Kopcinskiego Street 22, 90-153, Lodz, Poland

    Dariusz Szymanski, Adam Durczynski & Janusz Strzelczyk

Authors
  1. Dariusz Szymanski
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Adam Durczynski
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Janusz Strzelczyk
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Adam Durczynski.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Szymanski, D., Durczynski, A. & Strzelczyk, J. Two-Staged Surgery for Metastatic Liver Tumor in Morbidly Obese Individual-Left Hemihepatectomy Following Placement of Laparoscopic Adjustable Gastric Band. OBES SURG 21, 267–271 (2011). https://doi.org/10.1007/s11695-010-0097-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11695-010-0097-z

Keywords

Search

Navigation